Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    January 2017

  1. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    


    December 2016
  2. MICHAELS MG, Humar A
    Cytomegalovirus in the Pediatric Transplant Recipient: where are we now?
    Transplantation. 2016 Dec 31. doi: 10.1097/TP.0000000000001627.
    PubMed     Text format    


  3. ABATE D
    The First 90 Days: Temporary Effect of Alemtuzumab on CMV Immune Reconstitution.
    Transplantation. 2016.
    PubMed     Text format    


    November 2016
  4. GE S, Karasyov A, Sinha A, Petrosyan A, et al
    Cytomegalovirus Immunity after Alemtuzumab Induction in Desensitized Kidney Transplant Patients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    October 2016
  5. NICASTRO E, Giovannozzi S, Stroppa P, Callegaro AP, et al
    Effectiveness of preemptive therapy for Cytomegalovirus disease in pediatric liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    August 2016
  6. AVERY RK, Arav-Boger R, Marr KA, Kraus E, et al
    Outcomes in Transplant Recipients Treated with Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  7. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  8. NATORI Y, Humar A, Husain S, Rotstein C, et al
    Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    June 2016
  9. LOLLINGA WT, de Wit RH, Rahbar A, Vasse GF, et al
    Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    May 2016
  10. QESARI M, Richter A, Ogonek J, Mischak-Weissinger E, et al
    Cytomegalovirus-Specific T Cells Isolated by IFN-gamma Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    March 2016
  11. SCHULZ U, Solidoro P, Muller V, Szabo A, et al
    CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
    Transplantation. 2016;100 Suppl 3:S5-S10.
    PubMed     Text format     Abstract available


  12. REA F, Potena L, Yonan N, Wagner F, et al
    Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
    Transplantation. 2016;100 Suppl 3:S19-26.
    PubMed     Text format     Abstract available


  13. CARBONE J
    The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.
    Transplantation. 2016;100 Suppl 3:S11-8.
    PubMed     Text format     Abstract available


  14. GROSSI P, Mohacsi P, Szabolcs Z, Potena L, et al
    Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
    Transplantation. 2016;100 Suppl 3:S1-4.
    PubMed     Text format     Abstract available


    January 2016
  15. WESESLINDTNER L, Gorzer I, Roedl K, Kung E, et al
    Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  16. PARAJULI S, Muth BL, Turk JA, Astor BC, et al
    In Kidney Transplant Recipients With a Positive Virtual Crossmatch, High PRA was Associated With Lower Incidence of Viral Infections.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  17. LIMAYE AP, La Rosa C, Longmate J, Diamond DJ, et al
    Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.
    Transplantation. 2016;100:210-6.
    PubMed     Text format     Abstract available


    November 2015
  18. PERALDI MN, Berrou J, Venot M, Chardiny V, et al
    Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.
    Transplantation. 2015;99:2422-30.
    PubMed     Text format     Abstract available


    September 2015
  19. CASTON JJ, Castells L, Varo E, Gomez MA, et al
    Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    August 2015
  20. HOCKER B, Zencke S, Krupka K, Fichtner A, et al
    Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  21. NAGAI S, Mangus RS, Anderson E, Ekser B, et al
    Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single Center Experience With 210 Cases.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    July 2015
  22. LIONAKI S, Altanis N, Papaxoinis K, Delladetsima I, et al
    A Cytomegalovirus-related Pseudotumor in the Colon of A Renal Transplant Recipient Shrunk by Antiviral Therapy.
    Transplantation. 2015;99:e46-7.
    PubMed     Text format    


    March 2015
  23. VERGHESE PS, Schmeling DO, Knight JA, Matas AJ, et al
    The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Transplantation. 2015;99:602-8.
    PubMed     Text format     Abstract available


    February 2015
  24. DESAI R, Collett D, Watson CJ, Johnson PJ, et al
    Impact of Cytomegalovirus on Long-Term Mortality and Cancer Risk After Organ Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  25. SANTOS CA, Brennan DC, Yusen RD, Olsen MA, et al
    Incidence, Risk Factors and Outcomes of Delayed-Onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    January 2015
  26. GABARDI S, Asipenko N, Fleming J, Lor K, et al
    Evaluation of Low- Versus High-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  27. OPELZ G, Dohler B
    Reduced Rate of Cardiovascular Death After Cytomegalovirus Prophylaxis in Renal Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  28. UELAND T, Rollag H, Hartmann A, Jardine A, et al
    Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients.
    Transplantation. 2015;99:100-5.
    PubMed     Text format     Abstract available


    December 2014
  29. VERGHESE PS, Schmeling DO, Knight JA, Matas AJ, et al
    Valganciclovir Administration to Kidney Donors to Reduce the Burden of Cytomegalovirus and Epstein-Barr Virus Transmission During Transplantation.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    November 2014
  30. WOOD KJ, Mariat C, Thaunat O, Mousson C, et al
    Bridging innate with adaptive immunity in transplantation: triggers, sensors, and modulators.
    Transplantation. 2014;98:1021-4.
    PubMed     Text format     Abstract available


  31. MICHELO CM, van der Meer A, Tijssen HJ, Zomer R, et al
    KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    September 2014
  32. GONZALEZ-ESTRADA A, Fernandez J
    Novel valganciclovir desensitization protocol.
    Transplantation. 2014;98:e50-1.
    PubMed     Text format    


    July 2014
  33. AULAGNON F, Scemla A, DeWolf S, Legendre C, et al
    Diarrhea After Kidney Transplantation: A New Look at a Frequent Symptom.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    May 2014
  34. DAVID-NETO E, Triboni AH, Paula FJ, Vilas Boas LS, et al
    A Double-Blinded, Prospective Study to Define Antigenemia and Quantitative Real-Time Polymerase Chain Reaction Cutoffs to Start Preemptive Therapy in Low-Risk, Seropositive, Renal Transplanted Recipients.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: